- Home
- RCKT vs XPER Comparison
RCKT vs XPER Comparison
Compare RCKT & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- XPER
- Stock Information
- Founded
- RCKT 1999
- XPER 1990
- Country
- RCKT United States
- XPER United States
- Employees
- RCKT N/A
- XPER N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- XPER Semiconductors
- Sector
- RCKT Health Care
- XPER Technology
- Exchange
- RCKT Nasdaq
- XPER Nasdaq
- Market Cap
- RCKT 328.6M
- XPER 317.3M
- IPO Year
- RCKT N/A
- XPER 2003
- Fundamental
- Price
- RCKT $3.17
- XPER $6.63
- Analyst Decision
- RCKT Buy
- XPER Strong Buy
- Analyst Count
- RCKT 13
- XPER 2
- Target Price
- RCKT $12.88
- XPER $13.50
- AVG Volume (30 Days)
- RCKT 2.3M
- XPER 516.9K
- Earning Date
- RCKT 11-06-2025
- XPER 11-05-2025
- Dividend Yield
- RCKT N/A
- XPER N/A
- EPS Growth
- RCKT N/A
- XPER N/A
- EPS
- RCKT N/A
- XPER N/A
- Revenue
- RCKT N/A
- XPER $475,219,000.00
- Revenue This Year
- RCKT N/A
- XPER N/A
- Revenue Next Year
- RCKT $108.43
- XPER $5.70
- P/E Ratio
- RCKT N/A
- XPER N/A
- Revenue Growth
- RCKT N/A
- XPER N/A
- 52 Week Low
- RCKT $2.19
- XPER $5.69
- 52 Week High
- RCKT $18.89
- XPER $11.08
- Technical
- Relative Strength Index (RSI)
- RCKT 48.26
- XPER 55.67
- Support Level
- RCKT $3.13
- XPER $6.43
- Resistance Level
- RCKT $3.44
- XPER $6.96
- Average True Range (ATR)
- RCKT 0.17
- XPER 0.24
- MACD
- RCKT -0.01
- XPER 0.06
- Stochastic Oscillator
- RCKT 35.11
- XPER 65.54
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About XPER Xperi Inc.
Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.